Hai'er Biotechnology: Net profit is expected to decrease by 39.09% year-on-year in the first half of 2025.

Haier Bio announced that the operating income in the first half of 2025 was 1.196 billion yuan, a year-on-year decrease of 2.27%. The net profit attributable to shareholders of the listed company was 143 million yuan, a year-on-year decrease of 39.09%. The basic earnings per share was 0.45 yuan per share, a year-on-year decrease of 39.19%.